Aurélie Pétain Selected Research

Neutropenia

1/2018

Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aurélie Pétain Research Topics

Disease

2	Lymphoma (Lymphomas) 02/2020 - 12/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Neutropenia 01/2018
1	Poisoning 12/2015
1	Neoplasms (Cancer) 12/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2015
1	Iron Overload 04/2012
1	Body Weight (Weight, Body) 04/2012

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 02/2020 - 12/2015
2	PolyaminesIBA 02/2020 - 12/2015
2	F14512IBA 02/2020 - 12/2015
1	etoposide phosphate (Etopophos)FDA Link 02/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	vinflunineIBA 01/2018
1	PlatinumIBA 01/2018
1	TubulinIBA 01/2018
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2015
1	Topoisomerase II InhibitorsIBA 12/2015
1	SpermineIBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	EnzymesIBA 04/2012
1	Busulfan (Busulfex)FDA Link 04/2012

Therapy/Procedure

1	Therapeutics 01/2018
1	Injections 12/2015
1	Hematopoietic Stem Cell Transplantation 04/2012